{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:01:51Z","timestamp":1781665311254,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1038\/eye.2000.138","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T12:41:35Z","timestamp":1309956095000},"page":"515-518","source":"Crossref","is-referenced-by-count":15,"title":["Glaucoma medical treatment: Philosophy, principles and practice"],"prefix":"10.1038","volume":"14","author":[{"given":"Clive","family":"Migdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFeye2000138_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0002-9394(89)90221-3","volume":"107","author":"A Sommer","year":"1989","unstructured":"Sommer A . Intraocular pressure and glaucoma. Am J Ophthalmol 1989;107:186\u20138","journal-title":"Am J Ophthalmol"},{"key":"BFeye2000138_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0002-9394(89)90423-6","volume":"108","author":"DR Anderson","year":"1989","unstructured":"Anderson DR . Glaucoma: the damage caused by pressure. XLVI Edward Jackson memorial lecture. Am J Ophthalmol 1989;108:485\u201395","journal-title":"Am J Ophthalmol"},{"key":"BFeye2000138_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/eye.1989.84","volume":"3","author":"JL Jay","year":"1989","unstructured":"Jay JL, Allan D . The benefit of early trabeculectomy versus conventional medicine in primary open angle glaucoma relative to severity of disease. Eye 1989;3:528\u201335","journal-title":"Eye"},{"key":"BFeye2000138_CR4","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/S0161-6420(94)31120-1","volume":"101","author":"C Migdal","year":"1994","unstructured":"Migdal C, Gregory W, Hitchings R . Long term functional outcome of early surgery compared with laser and medicine in open angle glaucoma. Ophthalmology 1994;101:1651\u20137","journal-title":"Ophthalmology"},{"key":"BFeye2000138_CR5","unstructured":"Kobelt G . Health economics: an introduction to economic evaluation. London: Office of Health Economics, 1996."},{"key":"BFeye2000138_CR6","unstructured":"Garratt S, editor. Primary open angle glaucoma: preferred practice plan. San Francisco: American Academy of Ophthalmology, 1989."},{"key":"BFeye2000138_CR7","unstructured":"Kaufman PL, Mittag TW . Medical therapy of glaucoma. In: Posdos SM, Yanoff M, editors. Textbook of ophthalmology, vol 7, Glaucoma. London: Mosby, 1994."},{"key":"BFeye2000138_CR8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1001\/archopht.1978.03910060433007","volume":"96","author":"RL Coakes","year":"1978","unstructured":"Coakes RL, Brubaker RS . The mechanism of timolol in lower intraocular pressure. Arch Ophthalmol 1978;96:2045\u20138","journal-title":"Arch Ophthalmol"},{"key":"BFeye2000138_CR9","doi-asserted-by":"crossref","unstructured":"Levobunolol Study Group. Levobunolol: a beta adrenoreceptor antagonist effective in the long term treatment of glaucoma. Ophthalmology 1985;92:1271\u20136","DOI":"10.1016\/S0161-6420(85)33887-3"},{"key":"BFeye2000138_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0002-9394(14)76731-5","volume":"112","author":"JB Searle","year":"1991","unstructured":"Searle JB, Lustgarten JS, Podos SM . A clinical trial of metipranolol, a non-cardioselective beta adrenergic antagonist in ocular hypertension. Am J Ophthalmol 1991;112:302\u20137","journal-title":"Am J Ophthalmol"},{"key":"BFeye2000138_CR11","first-page":"43","volume":"102","author":"DP Berry","year":"1984","unstructured":"Berry DP, Van Buskirk EM, Shields MB . Betaxolol and timolol: a comparison of efficacy and side effects. Arch Ophthalmol 1984;102:43\u20135","journal-title":"Arch Ophthalmol"},{"key":"BFeye2000138_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/0002-9394(84)90250-2","volume":"98","author":"EM Van Buskirk","year":"1984","unstructured":"Van Buskirk EM, Fraunfelder FJ . Ocular beta-blockers and systemic effects. Am J Ophthalmol 1984;98:623.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2000138_CR13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/archopht.1991.01080090123036","volume":"109","author":"RF Wang","year":"1991","unstructured":"Wang RF, Searle JB, Rodos SM, Sugrue MF . MK-507 (L-671, 152): a topically active carbonic anhydrase inhibitor reduces aqueous humor production in monkeys. Arch Ophthalmol 1991;109:1297.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2000138_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/archopht.1992.01080160073033","volume":"100","author":"EA Lippa","year":"1992","unstructured":"Lippa EA, Carben LE, Elinger B, et al . Dose-response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 1992;100:495.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2000138_CR15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archopht.1995.01100080061030","volume":"113","author":"ER Strahlman","year":"1995","unstructured":"Strahlman ER, Tipping R, Vogel R . A double-masked randomised 1 year study comparing dorzolamide (Trusopt), timolol and betaxolol. Arch Ophthalmol 1995;113:1009\u201316","journal-title":"Arch Ophthalmol"},{"key":"BFeye2000138_CR16","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1016\/S0161-6420(98)91047-8","volume":"105","author":"CM Clineschmidt","year":"1998","unstructured":"Clineschmidt CM, Williams RD, Snyder E, Adamsons A . The Dorzolamide-Timolol Combination Study Group. A randomised trial in patients inadequately controlled with timolol alone, comparing the dorzolamide-timolol combination to monotherapy with timolol alone. Ophthalmology 1998;105:1952\u20139","journal-title":"Ophthalmology"},{"key":"BFeye2000138_CR17","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0161-6420(96)30509-5","volume":"103","author":"ER Strahlman","year":"1996","unstructured":"Strahlman ER, Vogel R, Tipping R, Clineschmidt CM . The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. Ophthalmology 1996;103:1283\u201393","journal-title":"Ophthalmology"},{"issue":"Suppl 2","key":"BFeye2000138_CR18","first-page":"569","volume":"41","author":"CB Toris","year":"1997","unstructured":"Toris CB, Yablonski ME, Camras CB, Brubaker RF . Mechanisms of ocular hypertensive effect of latanoprost and the maintenance of normal blood-aqueous barrier function. Surv Ophthalmol 1997;41 (Suppl 2):569\u201375.","journal-title":"Surv Ophthalmol"},{"key":"BFeye2000138_CR19","first-page":"417","volume":"312","author":"A Bill","year":"1989","unstructured":"Bill A . Uveoscleral drainage of aqueous humor: physiology and pharmacology. Prog Clin BioI Res 1989;312:417\u201327","journal-title":"Prog Clin BioI Res"},{"key":"BFeye2000138_CR20","first-page":"387","volume":"312","author":"PL Kaufman","year":"1989","unstructured":"Kaufman PL, Crawford K . Aqueous humor dynamics: how PGF2a lowers intraocular pressure. Prog Clin Biol Res 1989;312:387\u2013416","journal-title":"Prog Clin Biol Res"},{"key":"BFeye2000138_CR21","first-page":"1734","volume":"102","author":"A Aim","year":"1995","unstructured":"Aim A, Stjernschantz J . Scandinavian Latanoprost Study Group. Effects on lOP and side effects of 0.005% latanoprost OD, evening and morning: a comparison with timolol. Ophthalmology 1995;102:1734\u201352","journal-title":"Ophthalmology"},{"key":"BFeye2000138_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","volume":"103","author":"P Watson","year":"1996","unstructured":"Watson P, Stjernschantz J . Latanoprost Study Group. A six month randomised double-masked study comparing latanoprost to timolol in open angle glaucoma and ocular hypertension. Ophthalmology 1996;103:126\u201337","journal-title":"Ophthalmology"},{"key":"BFeye2000138_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","volume":"103","author":"CB Camras","year":"1996","unstructured":"Camras CB . United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six month masked, multicenter trial in the US. Ophthalmology 1996;103:138\u201347","journal-title":"Ophthalmology"},{"key":"BFeye2000138_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/bjo.79.1.12","volume":"79","author":"A Alm","year":"1995","unstructured":"Alm A, Wiodengard I, Kjellgren D, et al . Latanoprost administered once daily caused a maintained reduction of lOP in glaucoma patient treated concomitantly with timolol. Br J Ophthalmol 1995;79:12\u201316","journal-title":"Br J Ophthalmol"},{"key":"BFeye2000138_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/bjo.78.12.899","volume":"78","author":"AH Pulo","year":"1994","unstructured":"Pulo AH, Greve EL, Hoyng PF . Additive effect of latanoprost, a prostaglandin PGF2 analogue, and timolol in patients with elevated intraocular pressure. Br J Ophthalmol 1994;78:899\u2013902","journal-title":"Br J Ophthalmol"},{"issue":"Suppl 2","key":"BFeye2000138_CR26","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/S0039-6257(97)80019-7","volume":"41","author":"G Selen","year":"1997","unstructured":"Selen G, Stjernschantz J, Resul B . Prostaglandin-induced pigmentation in primates. Surv Ophthalmol 1997;41 (Suppl 2):S125\u20138.","journal-title":"Surv Ophthalmol"},{"key":"BFeye2000138_CR27","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/archopht.1995.01100120044006","volume":"113","author":"CB Toris","year":"1995","unstructured":"Toris CB, Gleason ML, Camras CB, Yablonski ME . Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol 1995;113:1514\u20137","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 1","key":"BFeye2000138_CR28","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/S0039-6257(96)82029-7","volume":"41","author":"JS Schuman","year":"1996","unstructured":"Schuman JS . Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension. Surv Ophthalmol 1996;41 (Suppl 1):S27\u201337.","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 1","key":"BFeye2000138_CR29","first-page":"539","volume":"41","author":"JB Searle","year":"1996","unstructured":"Searle JB . Brimonidine Study Group III. A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated IOP. Surv Ophthalmol 1996;41 (Suppl 1):539\u201347.","journal-title":"Surv Ophthalmol"},{"key":"BFeye2000138_CR30","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/archopht.116.12.1591","volume":"116","author":"Y Lachkar","year":"1998","unstructured":"Lachkar Y, Migdal C, Dhanjil S . Effect of brimonidine tartrate on ocular hemodynamic measurements. Arch Ophthalmol 1998;116:1591\u20134","journal-title":"Arch Ophthalmol"},{"key":"BFeye2000138_CR31","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/archopht.1982.01030040248007","volume":"100","author":"WF March","year":"1982","unstructured":"March WF, Stewart RM, Mandell AI, Bruce LA . Duration of effect of pilocarpine gel. Arch Ophthalmol 1982;100:1270.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2000138_CR32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1001\/archopht.1975.01010020665001","volume":"93","author":"HA Quigley","year":"1975","unstructured":"Quigley HA, Pollack IP, Harbin TS Jr . Pilocarpine Ocuserts: longterm clinical trials and selected pharmacodynamics. Arch Ophthalmol 1975;93:771.","journal-title":"Arch Ophthalmol"},{"issue":"Suppl","key":"BFeye2000138_CR33","first-page":"3405","volume":"36","author":"CM Clineschmidt","year":"1995","unstructured":"Clineschmidt CM, Strahlman ER, Anderson K . Timolol\/MK507: comparison of a fixed combination of dorzolamide and timolol (b.i.d.) to concomitant administration of dorzolamide (t.i.d.) plus timolol (b.i.d.) in patients with open angle glaucoma for three months. Invest Ophthalmol Vis Sci 1995;36 (Suppl):3405.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2000138_CR34","unstructured":"European Glaucoma Society. Terminology and guidelines for glaucoma. Savona: Dogma, 1998."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2000138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2000138","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2000138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:58:03Z","timestamp":1684429083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2000138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["BFeye2000138"],"URL":"https:\/\/doi.org\/10.1038\/eye.2000.138","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}